CNSP icon

CNS Pharmaceuticals

11 hedge funds and large institutions have $422K invested in CNS Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$335K 406,000 +406,000 New
UBS Group
2
UBS Group
Switzerland
$26.5K 32,103 +8,125 +34%
VF
3
Virtu Financial
New York
$19K 23,348 +23,348 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$14.7K 17,871 +17,871 New
TSS
5
Two Sigma Securities
New York
$12.9K 15,633 +15,633 New
HF
6
HRT Financial
New York
$8K 10,863 +10,863 New
TRCT
7
Tower Research Capital (TRC)
New York
$5.56K 6,738 +1,627 +32%
BC
8
Barrett & Company
Rhode Island
$83 100
Bank of America
9
Bank of America
North Carolina
$40 49 +40 +444%
MCM
10
MAI Capital Management
Ohio
$33 40
SS
11
SBI Securities
Japan
$11 13 -2 -13%
GSC
12
Ground Swell Capital
South Carolina
-11,341 Closed